Free Trial

UiPath (NYSE:PATH) Price Target Cut to $12.00 by Analysts at Morgan Stanley

UiPath logo with Business Services background
Remove Ads

UiPath (NYSE:PATH - Get Free Report) had its target price decreased by investment analysts at Morgan Stanley from $16.00 to $12.00 in a research report issued on Thursday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Morgan Stanley's target price points to a potential upside of 10.66% from the company's previous close.

Other equities research analysts have also issued research reports about the company. JPMorgan Chase & Co. upped their target price on UiPath from $17.00 to $18.00 and gave the company an "overweight" rating in a research report on Friday, December 6th. Barclays dropped their target price on UiPath from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Friday, January 10th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $16.00 target price on shares of UiPath in a research report on Friday, December 6th. Needham & Company LLC reiterated a "hold" rating on shares of UiPath in a research report on Wednesday, January 15th. Finally, UBS Group started coverage on UiPath in a research report on Thursday, December 12th. They issued a "sell" rating and a $14.00 target price on the stock. Two research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $14.53.

Get Our Latest Stock Analysis on UiPath

Remove Ads

UiPath Stock Up 8.8 %

Shares of PATH traded up $0.87 during mid-day trading on Thursday, hitting $10.84. 26,728,329 shares of the company traded hands, compared to its average volume of 9,474,543. UiPath has a 1-year low of $9.50 and a 1-year high of $23.97. The company has a market capitalization of $5.96 billion, a PE ratio of -67.78 and a beta of 1.00. The business has a 50 day moving average of $13.36 and a 200 day moving average of $13.15.

Insider Activity at UiPath

In related news, CAO Hitesh Ramani sold 25,000 shares of the stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $13.05, for a total value of $326,250.00. Following the completion of the transaction, the chief accounting officer now directly owns 269,421 shares of the company's stock, valued at approximately $3,515,944.05. This represents a 8.49 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Ashim Gupta sold 47,227 shares of the stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $13.06, for a total value of $616,784.62. Following the completion of the transaction, the chief financial officer now directly owns 856,538 shares of the company's stock, valued at approximately $11,186,386.28. This represents a 5.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 22.37% of the stock is owned by corporate insiders.

Institutional Trading of UiPath

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Norges Bank acquired a new stake in shares of UiPath during the 4th quarter worth about $71,191,000. Jacobs Levy Equity Management Inc. increased its position in shares of UiPath by 554.8% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 4,026,502 shares of the company's stock worth $51,539,000 after purchasing an additional 3,411,562 shares during the last quarter. Senvest Management LLC increased its position in shares of UiPath by 29.2% during the 4th quarter. Senvest Management LLC now owns 14,074,783 shares of the company's stock worth $178,890,000 after purchasing an additional 3,180,300 shares during the last quarter. AQR Capital Management LLC boosted its holdings in UiPath by 45.3% during the 4th quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company's stock valued at $84,209,000 after acquiring an additional 2,072,089 shares during the period. Finally, Worldquant Millennium Advisors LLC purchased a new position in UiPath during the 3rd quarter valued at about $19,071,000. 62.50% of the stock is owned by institutional investors and hedge funds.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

Analyst Recommendations for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Institutions Are Dumping These 3 Stocks—Should You?
Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads